home / stock / cort / cort articles

CORT Articles, Corcept Therapeutics Incorporated

Stock Information
Company Name: Corcept Therapeutics Incorporated
Stock Symbol: CORT
Market: NASDAQ
Menu
CORT CORT Quote CORT Short CORT News CORT Articles CORT Message Board
Get CORT Alerts

News, Short Squeeze, Breakout and More Instantly...
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call | Benzinga

MENLO PARK, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quar...
Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter | Benzinga

Monday, Corcept Therapeutics Incorporated (NASDAQ:CORT) released results from the open-label portion of the pivotal Phase 3 GRACE trial o...

What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday? | Benzinga

Thursday, Corcept Therapeutics Incorporated (NASDAQ:CORT) released announced preliminary results from the prevalence phase of its ongoing...

Significant Move: Gary Charles Robb Invests $105K In Corcept Therapeutics Stock Options | Benzinga

In a new SEC filing on February 14, it was unveiled that Robb, Chief Business Officer at Corcept Therapeutics (NASDAQ:CORT), acquired stock options...
A Noteworthy Decision By Atabak Mokari As Acquires $105K In Corcept Therapeutics Stock Options | Benzinga

A substantial insider move unfolded on February 14, as Mokari, Chief Financial Officer at Corcept Therapeutics (NASDAQ:CORT), reported the acquisit...

Hazel Hunt Sees Potential Growth And Acquires $105K In Corcept Therapeutics Stock Options | Benzinga

In a new SEC filing on February 14, it was unveiled that Hunt, Chief Scientific Officer at Corcept Therapeutics (NASDAQ:CORT), acquired stock optio...

Joseph Douglas Lyon Enhances Portfolio With Corcept Therapeutics Stock Options: $79K Acquired | Benzinga

A noteworthy insider acquisition was disclosed on February 14, as Lyon, Chief Accounting Officer at Corcept Therapeutics (NASDAQ:CORT), reported th...
William Guyer Expands Holdings With Corcept Therapeutics Stock Options | Benzinga

A noteworthy insider acquisition was disclosed on February 14, as Guyer, Chief Development Officer at Corcept Therapeutics (NASDAQ:CORT), reported ...

Joseph K Belanoff Makes A Tactical Move: Adds Corcept Therapeutics Stock Options To Portfolio | Benzinga

Disclosed in a recent SEC filing, Joseph K Belanoff, Chief Executive Officer at Corcept Therapeutics (NASDAQ:CORT), made a strategic move by acquir...

Corcept Appoints Roberto Vieira as President, Oncology | Benzinga

MENLO PARK, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the...
Next 10